Fresenius Medical Care AG & Co KGaA
XETRA:FME
Intrinsic Value
Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. [ Read More ]
The intrinsic value of one FME stock under the Base Case scenario is 81.31 EUR. Compared to the current market price of 39.54 EUR, Fresenius Medical Care AG & Co KGaA is Undervalued by 51%.
Valuation Backtest
Fresenius Medical Care AG & Co KGaA
Run backtest to discover the historical profit from buying and selling FME stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Fresenius Medical Care AG & Co KGaA
| Current Assets | 8.7B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 3.6B |
| Other Current Assets | 3.4B |
| Non-Current Assets | 25.2B |
| Long-Term Investments | 1.3B |
| PP&E | 7.5B |
| Intangibles | 16B |
| Other Non-Current Assets | 507.5m |
| Current Liabilities | 6.1B |
| Accounts Payable | 762.1m |
| Short-Term Debt | 456.9m |
| Other Current Liabilities | 4.9B |
| Non-Current Liabilities | 14.2B |
| Long-Term Debt | 10.5B |
| Other Non-Current Liabilities | 3.7B |
Earnings Waterfall
Fresenius Medical Care AG & Co KGaA
|
Revenue
|
19.5B
EUR
|
|
Cost of Revenue
|
-14.5B
EUR
|
|
Gross Profit
|
4.9B
EUR
|
|
Operating Expenses
|
-3.6B
EUR
|
|
Operating Income
|
1.3B
EUR
|
|
Other Expenses
|
-779.3m
EUR
|
|
Net Income
|
499m
EUR
|
Free Cash Flow Analysis
Fresenius Medical Care AG & Co KGaA
What is Free Cash Flow?
FME Profitability Score
Profitability Due Diligence
Fresenius Medical Care AG & Co KGaA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Fresenius Medical Care AG & Co KGaA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
FME Solvency Score
Solvency Due Diligence
Fresenius Medical Care AG & Co KGaA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Score
Fresenius Medical Care AG & Co KGaA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FME Price Targets Summary
Fresenius Medical Care AG & Co KGaA
According to Wall Street analysts, the average 1-year price target for FME is 39.62 EUR with a low forecast of 26.26 EUR and a high forecast of 52.5 EUR.
Shareholder Return
FME Price
Fresenius Medical Care AG & Co KGaA
| Average Annual Return | -14.89% |
| Standard Deviation of Annual Returns | 22.87% |
| Max Drawdown | -65% |
| Market Capitalization | 11.6B EUR |
| Shares Outstanding | 293 413 449 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 122,909 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The firm also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The firm supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Contact
IPO
Employees
Officers
The intrinsic value of one FME stock under the Base Case scenario is 81.31 EUR.
Compared to the current market price of 39.54 EUR, Fresenius Medical Care AG & Co KGaA is Undervalued by 51%.
You don't have any saved screeners yet
